The Centers for Medicare & Medicaid Services (CMS) yesterday proposed changing Medicare Part D rules to curb plan sponsors and pharmacy benefit managers’ skyrocketing use of direct and indirect renumeration fees (DIR)—PBMs’ controversial practice of clawing back drug payments to pharmacies after the point of sale.
In Big Win for Pharmacy Groups, CMS Proposes Significant Changes to Medicare Part D Clawbacks
